Analysis of the impact of PAPP-A, free β-hCG and nuchal translucency thickness on the advanced first trimester screening

被引:10
作者
Berktold, L.
v Kaisenberg, C. [1 ]
Hillemanns, P. [1 ]
Vaske, B. [2 ]
Schmidt, P. [1 ]
机构
[1] Hannover Med Sch, Dept Obstet & Gynaecol, Hannover, Germany
[2] Hannover Med Sch, Dept Med Stat & Biometry, Hannover, Germany
关键词
Advanced first trimester screening; First trimester screening; Trisomy; 21; Nuchal translucency; Biochemistry; HUMAN CHORIONIC-GONADOTROPIN; PLASMA PROTEIN-A; NICOLAIDES RISK-EVALUATION; DOWNS-SYNDROME; MATERNAL AGE; 1ST-TRIMESTER; TRISOMY-21; ULTRASOUND; AMNIOCENTESIS; MULTICENTER;
D O I
10.1007/s00404-012-2585-y
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The intention of this study is to analyze the impact of the single parameters NT, PAPP-A and free beta-hCG used in combined first trimester screening and to determine their contribution in the risk assessment. A retrospective risk assessment on the advanced first trimester screening (AFS) algorithm was made to determine the effect of a particular parameter while the remaining ones were fixed for calculation. Afterward data were recalculated by the AFS module. Test performance was measured by receiver operating characteristics (ROC) curves and their area under curve (AUC). Among the 14,862 cases are 14,748 healthy fetuses, 86 with trisomy 21, 22 with trisomy 18 and 6 with trisomy 13. Some settings obtain at default cut-off a very high sensitivity. However, a lack of specificity, as a high false-positive rate, too. The ROC analysis was best for NT, followed by PAPP-A. Free beta-hCG showed the lowest AUC. Combining PAPP-A and free beta-hCG offered a better AUC than each parameter alone. Best test performance was obtained by including all three parameters. A detection rate of 69 % for testing NT discretely is in order with present study data. PAPP-A is following and free beta-hCG is not useful with a test positive rate of about a third. The detection rate of the biochemical parameters combined is higher than for NT alone, but results in a five times higher punctuation rate. All parameters together in the AFS provide the best test performance. The impact of each parameter NT, PAPP-A and free-beta-hCG in a combined test strategy is nearly a third. Thus, every single parameter is needed to provide a high detection rate for all of the trisomies and minimize the number of unnecessary invasive diagnostics.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 63 条
[1]  
BENZ R, 1993, Z GEBURTSH PERINATOL, V197, P205
[2]  
Berry E, BR J OBSTET GYNECOL, V104, P811
[3]   One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies [J].
Bindra, R ;
Heath, V ;
Liao, A ;
Spencer, K ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2002, 20 (03) :219-225
[4]   THE DISAPPEARANCE RATE OF PREGNANCY-ASSOCIATED PLASMA PROTEIN-A (PAPP-A) AFTER THE END OF NORMAL AND ABNORMAL PREGNANCIES [J].
BISCHOF, P ;
AMAUDRUZ, M ;
WEILFRANCK, C ;
BAERISWYL, JP ;
WEIL, A ;
HERMANN, WL ;
SIZONENKO, PC .
ARCHIVES OF GYNECOLOGY, 1984, 236 (02) :93-98
[5]   ABNORMAL MATERNAL SERUM CHORIONIC-GONADOTROPIN LEVELS IN PREGNANCIES WITH FETAL CHROMOSOME-ABNORMALITIES [J].
BOGART, MH ;
PANDIAN, MR ;
JONES, OW .
PRENATAL DIAGNOSIS, 1987, 7 (09) :623-630
[6]   Nuchal translucency measurements: Frequency distribution and changes with gestation in a general population [J].
Braithwaite, JM ;
Morris, RW ;
Economides, DL .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 (12) :1201-1204
[7]   SERUM PAPP-A AND FREE BETA-HCG ARE FIRST-TRIMESTER SCREENING MARKERS FOR DOWN-SYNDROME [J].
BRAMBATI, B ;
TULUI, L ;
BONACCHI, I ;
SHRIMANKER, K ;
SUZUKI, Y ;
GRUDZINSKAS, JG .
PRENATAL DIAGNOSIS, 1994, 14 (11) :1043-1047
[8]   LOW MATERNAL SERUM LEVELS OF PREGNANCY ASSOCIATED PLASMA PROTEIN-A (PAPP-A) IN THE 1ST TRIMESTER IN ASSOCIATION WITH ABNORMAL FETAL KARYOTYPE [J].
BRAMBATI, B ;
MACINTOSH, MCM ;
TEISNER, B ;
MAGUINESS, S ;
SHRIMANKER, K ;
LANZANI, A ;
BONACCHI, I ;
TULUI, L ;
CHARD, T ;
GRUDZINSKAS, JG .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1993, 100 (04) :324-326
[9]   SERUM HUMAN CHORIONIC-GONADOTROPIN LEVELS THROUGHOUT NORMAL-PREGNANCY [J].
BRAUNSTEIN, GD ;
RASOR, J ;
ADLER, D ;
DANZER, H ;
WADE, ME .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1976, 126 (06) :678-681
[10]  
Cuckle HS, 1999, PRENATAL DIAG, V19, P505, DOI 10.1002/(SICI)1097-0223(199906)19:6<505::AID-PD572>3.0.CO